Park Ha Biological Technology is trading at $0.54 (-6.8%) in pre-market, ahead of an Extraordinary General Meeting scheduled for today, July 13, 2026.
- Shareholders are set to vote on a significant increase in authorized share capital and a proposed change to Class B share voting power from 20 to 100 votes each, which could reshape control dynamics.
- The stock continues its multi-day decline from a July 1 high of $0.92, following extreme volatility and speculative trading driven by its June AI-focused skincare partnership announcements.